Amanote Research
Register
Sign In
Brimonidine Purite 0.15% Versus Dorzolamide 2% Each Given Twice Daily to Reduce Intraocular Pressure in Subjects With Open Angle Glaucoma or Ocular Hypertension
British Journal of Ophthalmology
- United Kingdom
doi 10.1136/bjo.2003.032979
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Date
July 1, 2004
Authors
E D Sharpe
Publisher
BMJ
Related search
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Journal of Ocular Pharmacology and Therapeutics
Ophthalmology
Pharmacology
Safety and Tolerability of Tafluprost in Treatment of Elevated Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension
Clinical Ophthalmology
Ophthalmology
Tafluprost Once Daily for Treatment of Elevated Intraocular Pressure in Patients With Open-Angle Glaucoma
Clinical Ophthalmology
Ophthalmology
Ocular Blood Flow and Systemic Blood Pressure in Patients With Primary Open-Angle Glaucoma and Ocular Hypertension
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Fixed-Combination Brinzolamide 1%/Brimonidine 0.2% vs Monotherapy With Brinzolamide or Brimonidine in Patients With Open-Angle Glaucoma or Ocular Hypertension: Results of a Pooled Analysis of Two Phase 3 Studies
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Incident Open-Angle Glaucoma and Ocular Perfusion Pressure
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Brinzolamide/Brimonidine Fixed-Dose Combination Bid as an Adjunct to a Prostaglandin Analog for Open-Angle Glaucoma/Ocular Hypertension
European Journal of Ophthalmology
Medicine
Ophthalmology
Clinical Effectiveness of Brinzolamide 1%–brimonidine 0.2% Fixed Combination for Primary Open-Angle Glaucoma and Ocular Hypertension
Clinical Ophthalmology
Ophthalmology
EFFECT OF TOPICAL BRIMONIDINE 0.15% VERSUS TIMOLOL 0.5% TO PREVENT INTRAOCULAR PRESSURE ELEVATION AFTER Nd-Yag LASER CAPSULOTOMY
Journal of Evidence Based Medicine and Healthcare
